In this festive edition of Drug Safety Matters, we wrap up the year that was and look ahead to the year that will be – with a little help from one of our friends.


What did the drug safety community achieve in 2023 and how will the field develop in 2024? As the year comes to a close, we asked Angela Caro, president of the International Society of Pharmacovigilance, to walk us through current and future trends in pharmacovigilance.

Among her predictions, hear her thoughts on patient engagement – a hot topic that is going to get hotter – as well as the challenges she foresees closest to home in Latin America.

Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:

You may also like


Patient perspectives in PV at the ISoP Mid-Year Symposium – New podcast episode

Patient engagement was a hot topic at the fireside chat held during this year’s ISoP mid-year symposium.

24 June 2025

ISoP 2025 Cairo: A Global Perspective on the Evolution and Future of Pharmacovigilance

Over 500 attendees from 80+ countries met in Cairo at ISoP 2025, reflecting on pharmacovigilance progress and shaping strategies for its future.

10 December 2025

Linking Pharmacogenomics and Pharmacovigilance Data to Solve Drug-induced Problems

Pharmacovigilance has come a long way in helping us link medicines to their side-effects; with the help of pharmacogenomics it can go even further.

05 February 2025